I Holland Rolls out an Innovative New Packaging Solution to Eliminate Potential Tool Tip Damage?
I Holland has released a breakthrough new packaging solution to ensure its products arrive in perfect condition.
PrimePac tubes (patent pending), part of the company’s new portfolio of packaging, have been specifically designed with a ‘safety zone’ to hold tablet punches in position to stop damage to the tip face.
“One of the most important and fundamental problems when transporting tablet tooling is ensuring the punch tip face is undamaged. Any damage to the very delicate land area will result in reduction of punch life when the punch is placed under stress in operation,” explains Michael Oxford, R&D Engineer.
“Although our previous packaging tubes have served us well, we felt that re-designing them to incorporate an innovative safety zone ensures the quality of the product, knowing that it will arrive with the customer in the same quality condition that it left the factory. By designing the PrimePac range we can maintain our customer service and ensure the end user receives the best quality product available, something very important to I Holland.”
Current methods of packaging protection commonly used by punch and die manufacturers include foam inserts or cardboard inner tubes, which do not have the protective power of the new designed PrimePac solution. The new packaging tubes will be rolled out in the coming months.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.